Could modulation of SPDEF activity lower risk for metastatic prostate cancer?

Posted on April 4, 2013 by Sitemaster

According to an article just published in the Journal of Biological Chemistry, the authors have identified a biological molecule known as the SAM pointed domain ETS transcription factor or SPDEF controls the expression of E-cadherin — a protein that is known to be very important to the process of prostate cancer metastasis. … READ MORE …

Filed under: Drugs in development | Tagged: , , , | Leave a comment »